Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
| DRUGNAME | PT | EventCount |
|---|---|---|
| RITUXIMAB | West Nile viral infection | 1 |
| Rituximab | Wheelchair user | 1 |
| RITUXIMAB | White blood cell disorder | 1 |
| Rituximab | Wound | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Abscess | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Cellulitis | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Erythema | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Furuncle | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Hypogammaglobulinaemia | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Infection | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Musculoskeletal chest pain | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Pneumonia | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Pyrexia | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Sinusitis | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Skin infection | 1 |
| RITUXIMAB (MO AB C2B8 ANTI CD20, CHIMERIC) | Swelling | 1 |
| RITUXIMAB (MOAB C2B8 ANTI C20, CHIMERIC) | Febrile neutropenia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI C20, CHIMERIC) | Haemoglobin decreased | 1 |
| RITUXIMAB (MOAB C2B8 ANTI C20, CHIMERIC) | Platelet count decreased | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Abscess | 1 |
Total Records: 1,104 Number of Pages: 56